Safety and immunogenicity of acellular pertussis vaccine, combined with diphtheria and tetanus as the Japanese commercial Takeda vaccine, compared with the Takeda acellular pertussis component combined with Lederleʼs diphtheria and tetanus toxoids in two-, four- and six-month-old infants
- 1 November 1992
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 11 (11), 930-935
- https://doi.org/10.1097/00006454-199211110-00005